rusfertide

FDA Drug Profile — MIMRYLO

rusfertide is listed in the FDA National Drug Code directory with 20 NDC codes, marketed under brand name including MIMRYLO. Available dosage forms: kit, injection, powder, lyophilized, for solution.

Drug details

Generic Name
rusfertide
Brand Names
MIMRYLO
Application Number
NDA220605
Sponsor
Takeda Pharmaceuticals America, Inc.
NDC Codes
20
Dosage Forms
KIT, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
RUSFERTIDE ACETATE

Indications and Usage

1 INDICATIONS AND USAGE MIMRYLO is indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV). MIMRYLO is a hepcidin mimetic indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV). ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.